Efavirenz Interference in Estradiol ELISA Assay
نویسندگان
چکیده
منابع مشابه
Efavirenz interference in estradiol ELISA assay.
To the Editor: The prognosis of HIV infection has dramatically changed following the introduction of highly active antiretroviral therapy (HAART), a multidrug regimen usually consisting of three to four antiretroviral drugs belonging to the categories of nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs) and of protease inhibitors (PIs). The somewhat remarkable th...
متن کاملMicrotiter Immunocyto- chemical ELISA Assay
Quantitative assessment of immunoreactivity and protein expression in cultured cells can be time-consuming and subjective. The problem is magnified when rapid and efficient screening is required, and the supply of cells is limited. Immunoblot analysis requires protein extraction, quantification of protein content and gel electrophoresis, which make the method impractical for evaluating multiple...
متن کاملIn-Cell ELISA (ICE) Assay Platform
Apoptosis: Apoptosis is a self-killing mechanism of genetically-programmed cell death that is involved in normal development and homeostasis in the animal kingdom. The deregulation of apoptosis plays a major role in variety of pathologies, including cancer, autoimmunity, immunodeficiency and neurodegenerative disease (1-4). The apoptotic program of cell death is orchestrated by cysteine-depende...
متن کاملEfavirenz interference in urine screening immunoassays for tetrahydrocannabinol.
BACKGROUND It has been known for some time that the antiretroviral drug, efavirenz (EFV), cross-reacts in urine immunoassays for tetrahydrocannabinol (THC). Because published studies investigating this phenomenon are limited, cross-reactivity information for several immunoassays is lacking. Reports of possible false-positive THC results from clinicians conducting workplace testing prompted us t...
متن کاملAssay Interference by Aggregation
Aggregation is a common mechanism of compound-mediated assay interference encountered in high-throughput screening (HTS) and follow-up experiments. Compounds that form aggregates in situ can nonspecifically perturb biomolecules in biochemical and cell-based assays. Nonspecific bioactivity from aggregation can waste significant resources when unaccounted for in assay design and readout interpret...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Chemistry
سال: 2000
ISSN: 0009-9147,1530-8561
DOI: 10.1093/clinchem/46.5.734